Annual CFF
$36.52 M
-$51.33 M-58.43%
31 December 2023
Summary:
Tonix Pharmaceuticals Holding annual cash flow from financing activities is currently $36.52 million, with the most recent change of -$51.33 million (-58.43%) on 31 December 2023. During the last 3 years, it has fallen by -$86.59 million (-70.34%). TNXP annual CFF is now -82.81% below its all-time high of $212.49 million, reached on 31 December 2021.TNXP Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$42.91 M
+$35.88 M+510.75%
30 September 2024
Summary:
Tonix Pharmaceuticals Holding quarterly cash flow from financing activities is currently $42.91 million, with the most recent change of +$35.88 million (+510.75%) on 30 September 2024. Over the past year, it has increased by +$36.63 million (+583.85%). TNXP quarterly CFF is now -60.53% below its all-time high of $108.71 million, reached on 31 March 2021.TNXP Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$90.43 M
+$36.63 M+68.09%
30 September 2024
Summary:
Tonix Pharmaceuticals Holding TTM cash flow from financing activities is currently $90.43 million, with the most recent change of +$36.63 million (+68.09%) on 30 September 2024. Over the past year, it has increased by +$87.40 million (+2882.59%). TNXP TTM CFF is now -57.44% below its all-time high of $212.49 million, reached on 31 December 2021.TNXP TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TNXP Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -58.4% | +583.9% | +2882.6% |
| 3 y3 years | -70.3% | +13.0% | -56.6% |
| 5 y5 years | +55.1% | +850.3% | +307.5% |
TNXP Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -82.8% | at low | -40.6% | +473.1% | -57.4% | +1249.5% |
| 5 y | 5 years | -82.8% | +182.7% | -60.5% | +473.1% | -57.4% | +1249.5% |
| alltime | all time | -82.8% | -60.5% | +473.1% | -57.4% | +1249.5% |
Tonix Pharmaceuticals Holding Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $42.91 M(+510.7%) | $90.43 M(+68.1%) |
| June 2024 | - | $7.03 M(-3413.7%) | $53.80 M(+12.5%) |
| Mar 2024 | - | -$212.00 K(-100.5%) | $47.80 M(+30.9%) |
| Dec 2023 | $36.52 M(-58.4%) | $40.71 M(+548.9%) | $36.52 M(+1104.4%) |
| Sept 2023 | - | $6.27 M(+509.7%) | $3.03 M(-138.5%) |
| June 2023 | - | $1.03 M(-108.9%) | -$7.87 M(-112.4%) |
| Mar 2023 | - | -$11.50 M(-259.1%) | $63.28 M(-28.0%) |
| Dec 2022 | $87.84 M(-58.7%) | $7.23 M(-256.3%) | $87.84 M(-29.4%) |
| Sept 2022 | - | -$4.63 M(-106.4%) | $124.38 M(-25.5%) |
| June 2022 | - | $72.18 M(+452.5%) | $166.97 M(+42.9%) |
| Mar 2022 | - | $13.06 M(-70.2%) | $116.84 M(-45.0%) |
| Dec 2021 | $212.49 M(+72.6%) | $43.77 M(+15.3%) | $212.49 M(+1.9%) |
| Sept 2021 | - | $37.96 M(+72.2%) | $208.58 M(+9.4%) |
| June 2021 | - | $22.05 M(-79.7%) | $190.69 M(-6.1%) |
| Mar 2021 | - | $108.71 M(+172.7%) | $203.06 M(+64.9%) |
| Dec 2020 | $123.11 M(+852.9%) | $39.86 M(+98.6%) | $123.11 M(+35.0%) |
| Sept 2020 | - | $20.07 M(-41.7%) | $91.16 M(+20.6%) |
| June 2020 | - | $34.42 M(+19.7%) | $75.61 M(+81.7%) |
| Mar 2020 | - | $28.76 M(+263.4%) | $41.60 M(+222.0%) |
| Dec 2019 | $12.92 M(-45.1%) | $7.91 M(+75.3%) | $12.92 M(-41.8%) |
| Sept 2019 | - | $4.51 M(+982.7%) | $22.19 M(+7.9%) |
| June 2019 | - | $417.00 K(+471.2%) | $20.57 M(-10.9%) |
| Mar 2019 | - | $73.00 K(-99.6%) | $23.08 M(-1.9%) |
| Dec 2018 | $23.54 M(+27.1%) | $17.19 M(+494.7%) | $23.54 M(+215.1%) |
| Sept 2018 | - | $2.89 M(-1.4%) | $7.47 M(+63.1%) |
| June 2018 | - | $2.93 M(+450.8%) | $4.58 M(-74.5%) |
| Mar 2018 | - | $532.00 K(-52.4%) | $17.95 M(-3.1%) |
| Dec 2017 | $18.52 M(-9.7%) | $1.12 M(>+9900.0%) | $18.52 M(-16.8%) |
| Sept 2017 | - | $1000.00(-100.0%) | $22.26 M(-14.8%) |
| June 2017 | - | $16.30 M(+1378.9%) | $26.11 M(+20.9%) |
| Mar 2017 | - | $1.10 M(-77.3%) | $21.60 M(+5.4%) |
| Dec 2016 | $20.50 M | $4.86 M(+25.9%) | $20.50 M(+31.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2016 | - | $3.86 M(-67.3%) | $15.64 M(-48.7%) |
| June 2016 | - | $11.78 M(>+9900.0%) | $30.48 M(+63.5%) |
| Mar 2016 | - | $0.00(0.0%) | $18.64 M(-60.9%) |
| Dec 2015 | $47.69 M(-10.4%) | $0.00(-100.0%) | $47.69 M(-0.6%) |
| Sept 2015 | - | $18.69 M(<-9900.0%) | $48.00 M(+30.9%) |
| June 2015 | - | -$54.00 K(-100.2%) | $36.67 M(-0.5%) |
| Mar 2015 | - | $29.05 M(+9488.8%) | $36.86 M(-30.7%) |
| Dec 2014 | $53.22 M(+256.0%) | $303.00 K(-95.9%) | $53.22 M(-7.0%) |
| Sept 2014 | - | $7.37 M(+5526.7%) | $57.23 M(-4.7%) |
| June 2014 | - | $131.00 K(-99.7%) | $60.09 M(-0.5%) |
| Mar 2014 | - | $45.41 M(+951.0%) | $60.36 M(+303.8%) |
| Dec 2013 | $14.95 M(+99.5%) | $4.32 M(-57.7%) | $14.95 M(+7.7%) |
| Sept 2013 | - | $10.22 M(+2418.0%) | $13.88 M(+279.2%) |
| June 2013 | - | $406.00 K(>+9900.0%) | $3.66 M(+12.5%) |
| Mar 2013 | - | $0.00(-100.0%) | $3.26 M(-56.6%) |
| Dec 2012 | $7.49 M(+186.8%) | $3.26 M(>+9900.0%) | $7.49 M(+30.6%) |
| Sept 2012 | - | $0.00(0.0%) | $5.74 M(-8.7%) |
| June 2012 | - | $0.00(-100.0%) | $6.28 M(-4.0%) |
| Mar 2012 | - | $4.24 M(+182.3%) | $6.55 M(+150.6%) |
| Dec 2011 | $2.61 M(+87.7%) | $1.50 M(+175.9%) | $2.61 M(+4.4%) |
| Sept 2011 | - | $544.00 K(+105.3%) | $2.50 M(+27.7%) |
| June 2011 | - | $265.00 K(-12.5%) | $1.96 M(+15.6%) |
| Mar 2011 | - | $303.00 K(-78.2%) | $1.70 M(+21.8%) |
| Dec 2010 | $1.39 M(>+9900.0%) | $1.39 M(>+9900.0%) | $1.39 M(>+9900.0%) |
| Sept 2010 | - | $2000.00(>+9900.0%) | $2000.00(>+9900.0%) |
| June 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2009 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 2009 | - | $0.00(0.0%) | $7000.00(-86.0%) |
| Mar 2009 | - | $0.00(-100.0%) | $50.00 K(0.0%) |
| Dec 2008 | $50.00 K | $7000.00(-68.2%) | $50.00 K(+16.3%) |
| Sept 2008 | - | $22.00 K(+4.8%) | $43.00 K(+104.8%) |
| June 2008 | - | $21.00 K | $21.00 K |
FAQ
- What is Tonix Pharmaceuticals Holding annual cash flow from financing activities?
- What is the all time high annual CFF for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding annual CFF year-on-year change?
- What is Tonix Pharmaceuticals Holding quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding quarterly CFF year-on-year change?
- What is Tonix Pharmaceuticals Holding TTM cash flow from financing activities?
- What is the all time high TTM CFF for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding TTM CFF year-on-year change?
What is Tonix Pharmaceuticals Holding annual cash flow from financing activities?
The current annual CFF of TNXP is $36.52 M
What is the all time high annual CFF for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high annual cash flow from financing activities is $212.49 M
What is Tonix Pharmaceuticals Holding annual CFF year-on-year change?
Over the past year, TNXP annual cash flow from financing activities has changed by -$51.33 M (-58.43%)
What is Tonix Pharmaceuticals Holding quarterly cash flow from financing activities?
The current quarterly CFF of TNXP is $42.91 M
What is the all time high quarterly CFF for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high quarterly cash flow from financing activities is $108.71 M
What is Tonix Pharmaceuticals Holding quarterly CFF year-on-year change?
Over the past year, TNXP quarterly cash flow from financing activities has changed by +$36.63 M (+583.85%)
What is Tonix Pharmaceuticals Holding TTM cash flow from financing activities?
The current TTM CFF of TNXP is $90.43 M
What is the all time high TTM CFF for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high TTM cash flow from financing activities is $212.49 M
What is Tonix Pharmaceuticals Holding TTM CFF year-on-year change?
Over the past year, TNXP TTM cash flow from financing activities has changed by +$87.40 M (+2882.59%)